MEMBRANE PERMEABILIZATION BY DIFFERENT REGIONS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN GP41

被引:44
作者
ARROYO, J
BOCETA, M
GONZALEZ, ME
MICHEL, M
CARRASCO, L
机构
[1] UNIV AUTONOMA MADRID, CSIC, CTR NACL BIOTECNOL, E-28049 MADRID, SPAIN
[2] UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC, E-28049 MADRID, SPAIN
关键词
D O I
10.1128/JVI.69.7.4095-4102.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The transmembrane glycoprotein (gp41) of human immunodeficiency virus type 1 (HIV-1) has been implicated in the cytopathology observed during HIV infection. The first amino acids located at the amino terminus are involved in membrane fusion and syncytium formation, while sequences located at the carboxy terminus have been predicted to interact with membranes and modify membrane permeability. The HIV-1 gp41 gene has been cloned and expressed in Escherichia coli cells by using pET vectors to analyze changes in membrane permeability produced by this protein. This system is well suited for expressing toxic genes in an inducible manner and for analyzing the function of proteins that modify membrane permeability. gp41 enhances the permeability of the bacterial membrane to hygromycin B despite the low level of expression of this protein. To localize the regions of gp41 responsible for these effects, a number of fragments spanning different portions of gp41 were inducibly expressed in E. coli. Two regions of gp41 were shown to increase membrane permeability: one located at the carboxy terminus, where two highly amphipatic helices have been predicted, and another one corresponding to the membrane-spanning domain. Expression of the central region of gp41 comprising this domain was highly lytic for E. coli cells and increased membrane permeability to a number of compounds. These findings are discussed in the light of HIV-induced cytopathology and gp41 structure.
引用
收藏
页码:4095 / 4102
页数:8
相关论文
共 55 条
  • [1] ACTION OF MEMBRANE-ACTIVE COMPOUNDS ON MAMMALIAN-CELLS - PERMEABILIZATION OF HUMAN-CELLS BY IONOPHORES TO INHIBITORS OF TRANSLATION AND TRANSCRIPTION
    ALONSO, MA
    CARRASCO, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1980, 109 (02): : 535 - 540
  • [2] REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - IMPLICATIONS FOR PATHOGENESIS
    ANTONI, BA
    STEIN, SB
    RABSON, AB
    [J]. ADVANCES IN VIRUS RESEARCH, VOL 43, 1994, 43 : 53 - 145
  • [3] TARGET CELL-SPECIFIC DETERMINANTS OF MEMBRANE-FUSION WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 3RD-VARIABLE REGION AND GP41 AMINO TERMINUS
    BERGERON, L
    SULLIVAN, N
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (04) : 2389 - 2397
  • [4] INTERACTIONS BETWEEN MEMBRANES AND CYTOLYTIC PEPTIDES
    BERNHEIMER, AW
    RUDY, B
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 864 (01) : 123 - 141
  • [5] IDENTIFICATION OF THE FUSION PEPTIDE OF PRIMATE IMMUNODEFICIENCY VIRUSES
    BOSCH, ML
    EARL, PL
    FARGNOLI, K
    PICCIAFUOCO, S
    GIOMBINI, F
    WONGSTAAL, F
    FRANCHINI, G
    [J]. SCIENCE, 1989, 244 (4905) : 694 - 697
  • [6] CHANGES IN THE CYTOPATHIC EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ASSOCIATED WITH A SINGLE AMINO-ACID ALTERATION IN THE ECTODOMAIN OF THE GP41 TRANSMEMBRANE GLYCOPROTEIN
    CAO, J
    VASIR, B
    SODROSKI, JG
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4662 - 4668
  • [7] EFFECTS OF AMINO-ACID CHANGES IN THE EXTRACELLULAR DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 ENVELOPE GLYCOPROTEIN
    CAO, J
    BERGERON, L
    HELSETH, E
    THALI, M
    REPKE, H
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (05) : 2747 - 2755
  • [8] CARRASCO L, 1993, NATO ADV SCI INST SE, V240, P283
  • [9] MEMBRANE LEAKINESS AFTER VIRAL-INFECTION AND A NEW APPROACH TO DEVELOPMENT OF ANTI-VIRAL AGENTS
    CARRASCO, L
    [J]. NATURE, 1978, 272 (5655) : 694 - 699
  • [10] CARRASCO L, 1995, ADV VIRUS RES, V45, P61, DOI 10.1016/S0065-3527(08)60058-5